Numerous studies have attempted to develop a new in vitro eye irritation test (EIT). To obtain more reliable results from EIT, potential new biomarkers that reflect eye irritation by chemicals must be identified. We investigated candidate biomarkers for eye irritation, using a proteomics approach. Sodium lauryl sulfate (SLS) or benzalkonium chloride (BAC) was applied on a reconstructed human cornea-like epithelium model, MCTT HCE, and corneal protein expression was examined by twodimensional gel electrophoresis. We found that ezrin (EZR) was significantly upregulated by SLS or BAC. In addition, upregulation of EZR in immortalized human corneal cells treated with SLS or BAC was confirmed by quantitative reverse transcription-PCR and western blot analysis. Furthermore, other well-known eye irritants such as cetylpyridinium bromide, Triton X-100, cyclohexanol, ethanol, 2-methyl-1-pentanol, and sodium hydroxide significantly increased EZR expression in immortalized human corneal cells. Induction of EZR promoter activity in irritant-treated human corneal cells was confirmed by a luciferase gene reporter assay. In conclusion, EZR expression may be a potential biomarker for detecting eye irritation, which may substantially improve the performance of in vitro EIT.
Human corneal cells or 3D reconstructed human cornea-like epithelium (RhCE) models are widely employed to predict human responses to ocular irritants. The criteria for eye irritation potential assessment adopted in these methods are typically viability thresholds. However, eye irritation potential assessment using tissue viability thresholds can lead to considerable misclassification of nonirritating substances as moderate or weak eye irritant, reducing test performance, particularly with respect to specificity and accuracy (Jang et al., 2015; Jung et al., 2011; Yang et al., 2017) . As a result, the specificities of cell-based and RhCE-based methods remain below or around 70%. Thus, to increase in vitro test performance, a new eye irritation biomarker should be identified that can complement the predictive capacity for eye irritation potential rather than relying solely on viability measurements (Choi et al., 2015; Meloni et al., 2010) . Several studies have attempted to employ transcriptomics to explore specific gene markers for irritants. Choi et al. (2015) found cornifelin (CNFN) and early growth response protein-1 (EGR-1) as potential biomarkers for eye irritation using a transcriptomic approach. Increased expression of CNFN and EGR-1 in an RhCE model MCTT HCE treated with 3 surfactants, sodium lauryl sulfate (SLS), benzalkonium chloride (BAC), and Triton X-100 (TX-100) as eye irritants was detected by performing wholegene microarray and quantitative reverse transcription (qRT)-PCR. Particularly, CNFN is expressed in barrier-related diseases such as psoriasis and atopic dermatitis. This suggests that when CNFN expression is increased by eye irritants, barrier function is enhanced through cornification to inhibit further penetration of eye irritants. This hypothesis supported that CNFN can be used as an eye-irritation biomarker. Similarly, Borlon et al. (2007) conducted a study to identify biomarkers for skin irritation in 3D human epidermal model EPISKIN using toxicogenomics technology. The researchers selected 4 irritants and 4 nonirritants from 20 standard chemicals and applied them to the EPISKIN. Using low-density DNA array, the expression patterns of 240 genes involved in cell senescence and stress responses were compared between skin stimulants and nonstimulant treated models. Sixteen genes showed expression changes by skin irritants as transcriptomic biomarkers useful in determining skin irritants. However, no studies have used proteomics to identify biomarkers of eye irritation in an in vitro EIT. When analyzing the response to stress, an organism's response to abiotic stress, which is the ability of an organism to survive and reproduce (also known as fitness) is a crucial factor. Fitness at the biochemical level is largely the consequence of the ability of appropriate proteins to function in response to intracellular and extracellular environments and regulate various functions of individual cells and cell organelles. Therefore, it is important to analyze changes in protein expression and activity in response to stress. In addition, the transcriptome is affected by numerous variables that alter protein expression levels during pre-, co-, and post-translational modification processes, alternative splicing, and protein degradation until a mature protein is produced (Feder and Walser, 2005) . From this perspective, proteomics rather than transcriptomics is more suited for identifying proteins that perform intracellular functions in response to eye irritation, which can lead to in-depth studies of the mechanisms of intracellular changes and biomarkers for eye irritation.
In this study, we investigated potential eye irritation biomarkers using a proteomic approach in an RhCE model, MCTT HCE, which is prepared using primary human corneal cells. SLS and BAC, representatives anionic and cationic surfactants, were selected as reference eye irritants (Choi et al., 2015; Grant and Acosta, 1996) . Identified corneal protein markers were verified using immortalized human corneal cells with SLS or BAC by examining their expression. Finally, we have identified the utility of ezrin (EZR), a candidate biomarker for the discrimination of eye irritation, by using other well-known eye irritants.
MATERIALS AND METHODS
Reagents. SLS was purchased from MP Biomedicals (Santa Ana, CA). BAC, cetylpyridinium bromide (CPB), cyclohexanol, 2-methyl-1-pentanol, and Triton X-100 (TX-100) were purchased from Sigma-Aldrich (St. Louis, MO). Ethanol (ETOH) was purchased from Merck (Darmstadt, Germany). Sodium hydroxide (NaOH) was purchased from Duchefa Biochemie (Haarlem, Netherland). The physicochemical characteristic and eye irritation information on these chemicals are listed in Table 1 . Fetal bovine serum (FBS) and enhanced chemiluminescence (ECL) detecting reagent were purchased from Thermo Fisher Scientific (Waltham, MA). A BCA protein assay kit was purchased from Pierce Chemical Co. (Rockford, IL). Cell proliferation reagent WST-1 was purchased from Roche (Basel, Switzerland). An EZ-CYTOX cell viability kit was purchased from Daeil Lab Service Co., Ltd (Seoul, Korea). Rabbit polyclonal antibody for EZR, mouse monoclonal antibody for b-actin, Texas Redconjugated goat antirabbit IgG, and UltraCruz Mounting Medium were purchased from Santa Cruz Biotechnology (Dallas, TX). Horseradish peroxidase (HRP)-conjugated goat antirabbit IgG was purchased from Bethyl (Montgomery, TX). Moloney murine leukemia virus (M-MLV) reverse transcriptase and RNase inhibitor (RNasin) were obtained from Promega (Madison, WI). SYBR Premix was purchased from QIAGEN (Hilden, Germany). Other chemicals and reagents were of the highest quality commercially available.
Cell culture. MCTT HCE was purchased from Biosolution Co., Ltd (Seoul, Korea). Upon receiving the MCTT HCE, 0.9 ml of fresh maintenance medium (DMEM/F-12 3:1 mixture supplemented with 5 lg/ml insulin, 0.4 lg/ml hydrocortisone, 1 ng/ml epidermal growth factor, 1% penicillin-streptomycin and 10% FBS) was replenished and incubated at 37 C under 5% CO 2 for 24 h. Cell viability of the MCTT HCE was evaluated as described previously (Jung et al., 2011) . Briefly, MCTT HCE in the 6-well plate was exposed to 40 ll of the test chemical solution for 10 min. Human cornea tissues were washed 4 times with phosphate-buffered saline (PBS) and incubated with fresh maintenance medium for 16 6 1 h (postincubation period) at 37 C under 5% CO 2 . Human corneal cells immortalized by human papillomavirus E6/E7 were cultured in DMEM supplemented with 10% heatinactivated FBS, 100 U/ml penicillin, and 100 lg/ml streptomycin. Cells were maintained at 37 C in a humidified atmosphere of 5% CO 2 . To apply eye irritants to cells, 1 Â 10 6 cells were seeded as a monolayer in DMEM supplemented with 10% FBS onto 60-mm dish plates and cultured under 37 C in a humidified atmosphere of 5% CO 2 for 48 h. Cells were exposed to 3 ml of the test substance solution for 10 min, washed with PBS and incubated with fresh maintenance medium for 16 6 1 h at 37 C under 5% CO 2 .
Cell viability assay. MCTT HCE was incubated with 300 ll of WST-1 solution in the dark for 3 h, extracts (100 ll) were transferred into a 96-well plate, and absorbance was measured at 450 nm using a Sunrise microplate reader (Tecan, M€ annedorf, Switzerland) . The selected viability cutoff point was set to 75 6 10%. For eye irritation experiments, immortalized human corneal cells (1 Â 10 4 cells/well) were added to a 96-well plate, and incubated for the designated time at 37 C under 5% CO 2 .
Referring to the experimental method of OECD test guideline 491, cells cultured in 96-well plate were exposed to 200 ll/well of the test chemical solution (OECD, 2017) . The cells were incubated with the test chemical solution for 10 min, washed with the PBS, and incubated in fresh maintenance medium for 16 6 1 h at 37 C under 5% CO 2 . After incubation, the cells were treated with 10 ll of EZ-CYTOX for 1 h. Absorbance was measured at 450 nm using a Sunrise microplate reader.
Two-dimensional gel electrophoresis/MALDI-TOF-MS analysis. To prepare total cell lysates, cells were solubilized in ice-cold 50 mM Tris-HCl (pH 8.0) containing 150 mM NaCl, 1% Nonidet P-40, 1 mM PMSF, 1 lg/ml aprotinin, and 1 lg/ml leupeptin (pH 7.4). Extracted proteins (200 lg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 10% polyacrylamide gels. Separated proteins were detected by silver staining. For protein identification by peptide mass fingerprinting, protein spots were excised, digested with trypsin (Promega), mixed with a-cyano-4-hydroxycinnamic acid in 50% acetonitrile/0.1% trifluoroacetic acid, and subjected to MALDI-TOF analysis (Ettan MALDI-TOF Pro, Amersham Biosciences, Amersham, UK) as previously described (Fernandez et al., 1998) . Spectra were collected from 350 shots per spectrum over an m/z range of 600-3000 and calibrated by two-point internal calibration using trypsin auto-digestion peaks (m/z 842.5099, 2211.1046). The peak list was generated using Ettan MALDI-TOF Pro Evaluation Module (version 2.0.16). Thresholds used for peak-picking were as follows: 5000 for minimum resolution of monoisotopic mass, 2.5 for S/N. The search program MASCOT (http://www.matrixscience.com/) was used for protein identification by peptide mass fingerprinting.
RT-PCR and quantitative RT-PCR. Total RNA was extracted using Ribospin (GeneALL, Seoul, Korea). Total RNA (1 lg) was transcribed at 37 C for 1 h in a total volume of 25 ll including 200 U of M-MLV reverse transcriptase, 40 U of RNase inhibitor, 5 ll of 5Â RT buffer, 1 mM dNTPs, and 100 pmol of oligo-dT primer. Reaction solutions containing 0.8 ll of cDNA from each sample were amplified with 10 pmol of oligonucleotide primers for each target gene, 0.2 mM dNTPs, 1.5 mM MgCl 2 , and 1. Western blotting. Whole cell lysates were prepared and protein concentration was determined using BCA Protein Assay Reagents (Pierce). Cellular extracts (20 lg) were separated on 10% SDS-PAGE at 100 V and transferred onto a 0.45 lm polyvinylidene fluoride membrane. Nonspecific binding was blocked with 5% nonfat milk in Tris-buffered saline containing 0.1% Tween-20 (TBS-T) for 2 h at 4 C. Membranes were then incubated overnight with the primary antibody specific for EZR at a 1:1000 dilution in TBS-T. HRP-conjugated secondary antibody (1:5000) was incubated with the membrane at 4 C for 2 h.
Proteins were visualized by an ECL method (Thermo), and band intensity was analyzed with a ChemiDoc XRS densitometer and quantified by Quantity One software (Bio-Rad).
EZR promoter-luciferase gene reporter assay. The pEZX-PG04-EZR reporter vector was constructed by inserting the EZR promoter construct amplified by PCR from genomic DNA. The primer sets used were as follows: sense:
The EZR promoter construct contained nt -1112 to þ50 from the transcription start site of EZR. The EZR promoter was ligated into pEZX-PG04 (GeneCopoeia, San Diego, CA) which had been digested with EcoRI and HindIII. The pEZX-PG04-EZR reporter vector includes Gaussia luciferase (GLuc) and secreted alkaline phosphatase (SEAP) genes under control of the EZR and CMV promoters, respectively. Immortalized human corneal cells (2 Â 10 6 ) were transfected with 2 lg of the reporter vector, using the Neon transfection system (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. After transfection, the cells were cultured in 12-well plate (1 Â 10 5 cells/well) in antibiotic-free DMEM with 10% FBS for 48 h. All chemicals were applied to the cells at a concentration that resulted in cell viability of approximately 75 6 10% (CV 75), twice the dilution of CV 75, and twice the concentration of CV 75. Cells were exposed to 1 ml of the test substance solution for 10 min, washed with 2 ml PBS, and incubated with in fresh maintenance medium for 16 6 1 h at 37 C under 5% CO 2 . Following incubation of irritant-treated cells, activities of secreted GLuc and SEAP were measured in the culture media using a Secrete-Pair Luminescence assay kit (GeneCopoeia) according to the manufacturer's instructions. The luminescence intensities (relative light units) were measured at 480 nm using a FilterMax F3 multi-mode microplate reader (Molecular Devices, Sunnyvale, CA). Because eye irritants affected cell viability, the ratio of luminescence intensities of GLuc to SEAP was calculated. Changes in EZR promoter activity were measured quantitatively by comparing the normalized GLuc activities (GLuc/SEAP ratio) of irritant-treated cells with the GLuc/ SEAP ratio of the control group treated with PBS or mineral oil.
Immunofluorescence. Cells were seeded on coverslips and subsequently washed with PBS after incubation with chemicals for the designated times and fixed with 4% paraformaldehyde for 30 min at 25 C. After washing, the cells were blocked for 30 min in PBS containing 5% goat serum and 0.2% TX-100. The cells were incubated with primary antibody specific for EZR overnight, washed extensively, and stained with Texas Red-conjugated goat antirabbit IgG (1:500) overnight. Following additional washing, the coverslips were mounted onto glass slides, using 3 ll of UltraCruz Mounting Medium containing DAPI (Santa Cruz). Fluorescence was observed using an LSM700 Confocal Laser Scanning Microscope (Carl Zeiss, Jena, Germany).
Immunohistochemistry. For immunohistochemistry analysis, samples were fixed in 4% paraformaldehyde and then embedded in paraffin. The sections were deparaffinized and rehydrated sequentially. Antigen retrieval was carried out using pH 6.0 Target Retrieval solution (DAKO, Carpinteria, CA) in a pressure cooker for 15 min. After cooling for more than 1 h on ice, the sections were incubated in 3% H 2 O 2 for 30 min to block endogenous peroxidase activity. The sections were washed twice with PBS and incubated with Protein block serum-free (DAKO) for 1 h at 25 C to reduce nonspecific signals. Sections were incubated overnight at 4 C with primary antibody specific for EZR at a 1:200 dilution. After washing 3 times with PBS, the sections were incubated for 15 min with HRP-conjugated rabbit secondary antibody (DAKO) at 25 C. DAB (DAKO) was used for antibody development and Mayer's Hematoxylin (DAKO) was used for counter staining.
Statistical analysis. One-way analysis of variance was performed followed by Dunnett's multiple comparison t-test using GraphPad Prism Software (GraphPad Software Inc., La Jolla, CA) when appropriate. The difference was considered statistically significant at p < .05.
RESULTS

Selection of Eye Irritant for Eye Irritation Test and Evaluation of Toxicity Using MCTT HCE Model
Of well-known eye irritants, we chose SLS and BAC, which represent anionic and cationic surfactants, respectively (Choi et al., 2015; Jung et al., 2011; Yun et al., 2016) . The WST-1 cell viability assay was conducted to determine the concentration-dependent effect of the selected chemicals on tissue viability to identify the optimal concentration of eye irritants to obtain an amount of testable protein from the RhCE model. SLS (1%) was used as a positive control to confirm that MCTT HCE reflects the appropriate cytotoxicity of eye irritants (Choi et al., 2015; Jung et al., 2011) . Figure 1 shows that SLS (0.1%, 0.3%, and 1%) or BAC (0.01% and 0.03%) significantly induced cytotoxicity in 3D models in a concentration-dependent manner.
Proteomic Analysis for Investigating Potential Biomarker Proteins for Eye Irritation
To extract protein from MCTT HCE, a concentration range of eye irritant chemical resulting in approximately 75 6 10% tissue viability (SLS: 0.1% and 0.3%; BAC: 0.01% and 0.03%) was selected; at this concentration range, a sufficient amount of protein is obtained from the model and the appropriate eye irritation response can be observed. Two-dimensional gel electrophoresis ( Figure 2A ) was performed to identify proteins showing significantly altered expression in MCTT HCE treated with eye irritants. As shown in Figure 2A , when a 3D model was treated with various concentrations of SLS or BAC, numerous spots were induced, reflecting the expression of the protein through increased intensity of the spot compared with in the PBStreated 3D model. Seven spots were identified to be commonly increased by SLS and BAC ( Figure 2B ). MALDI-TOF analysis was used to analyze spots with increased intensity. We identified 7 proteins showing strongly altered expression in response to SLS or BAC (Table 2) . Expression of all 7 proteins including translation control tumor protein isoform 2 (TCTP), Eif4a, actin-related protein 3 (ACTR3), lactate dehydrogenase B (LDHB), enolase 1, Tcomplex protein 1 subunit b (CCT2), and EZR were commonly upregulated by at least more than 1.5-fold by both SLS and BAC ( Table 2 ), suggesting that expression of these proteins is strongly correlated with cellular responses against external stimulation and are potential biomarkers for eye irritations. Particularly, expression of LDHB and EZR was strongly enhanced (17.22-and 10.00-fold, respectively) by 0.01% of BAC which causes approximately 95% of tissue viability in MCTT HCE. These results indicate that the expression of LDHB and EZR is sensitively enhanced by weak eye irritants.
Selection of EZR as a Biomarker Candidate for Eye Irritation
To determine whether SLS or BAC induces expression of the identified genes in immortalized human corneal cells, we examined the mRNA level of these genes in SLS-or BAC-treated cells by qRT-PCR. In the cell viability assay, we observed Figure 3A ). Similar to previous experiments, we selected a range of concentrations that would lead to a cell viability of approximately 75 6 10% (SLS: 0%, 1.25 Â 10 À3 %, 2.5 Â 10 À3 %, and 5 Â 10 À3 %; BAC: 0%, 1.25 Â 10 À3 %, 2.5 Â 10 À3 %, and 5 Â 10 À3 %). Of the genes identified in previous experiments, only EZR showed dramatic upregulation of mRNA by SLS by 11-fold ( Figure 3B and Table 3 ). Additionally, BAC treatment of immortalized corneal cells altered EZR expression by up to 6-fold at the mRNA level. EZR mRNA expression appeared to be SLS and BAC concentration-dependent in both RT-PCR and qRT-PCR ( Figure 3B ). Consistent with the increased mRNA levels, the protein levels and promoter activity of EZR were increased in a concentration-dependent manner by SLS or BAC (Figs. 3C and  3D ). These results show that EZR expression is closely related to the decrease in cell viability, and we hypothesized that EZR expression reflects the degree of cytotoxicity of immortalized human corneal cells. In previous studies, EZR was found to perform functions related to cell proliferation, morphological changes, and cell motility. In many cases, EZR migrates to the nucleus or cell membrane when performing these functions (Batchelor et al., 2004; Gavert et al., 2010; Kishore et al., 2005; Yang and Hinds, 2003) . In this regard, we observed EZR expression and intracellular location changes in immortalized human corneal cells treated with SLS or BAC by confocal microscopy. Interestingly, we observed not only increased expression of EZR by eye irritants, but also translocation of EZR into the nuclear fraction. Similar to trends in expression changes, the degree of EZR nuclear translocation was closely correlated with increased cytotoxicity expressed by intracellular nuclear decay ( Figure 3E ). Additionally, we investigated the effects of eye irritants on EZR expression and the intracellular location in MCTT HCE. Application of 2% SLS not only induced degradation of epithelial corneocytes, but also increased the expression of EZR and its translocation to the nucleus ( Figure 3F ). This result suggests that there is a close relationship between the cellular pathway of eye irritation and intracellular function of EZR in the nuclear fraction.
Induction of EZR Expression by Various Eye Irritants
Previous results indicated that application of SLS or BAC to immortalized human corneal cells can induce cytotoxicity, as well as significantly induce mRNA/protein expression and promoter activity of EZR. To propose EZR as a general biomarker to confirm eye irritation, we determined whether a variety of different eye irritants can induce EZR expression. We selected 6 eye irritants from various chemical classes, described in previous studies (Jung et al., 2011; Pfannenbecker et al., 2013) . We selected CPB, and TX-100 as surfactants, cyclohexanol, ETOH, and 2-methyl-1-pentanol as alcohols, and NaOH as an alkaline solution. All selected chemicals induced concentration-dependent cytotoxicity at the designated concentration range of immortalized human corneal cells ( Figure 4A ). We applied these eye irritants at the appropriate concentrations (concentrations causing 75 6 10% cell viability; CPB: 0%, 1.25 Â 10 À3 %, 2.5 Â 10 À3 %, and 5 Â 10 À3 %; TX-100: 0%, 2.5 Â 10 À3 %, 5 Â 10 À3 %, and 1 Â 10 À2 %; cyclohexanol: 0%, 0.25%, 0.5%, and 1%; ETOH: 0%, 5%, 10%, and 15%; 2-methyl-1-pentanol: 0%, 0.625%, 1.25%, and 2.5%; NaOH: 0%, 3.125 Â 10 À3 %, 6.25 Â 10 À3 %, and 1.25 Â 10 À2 %) and examined the mRNA expression of EZR by RT-PCR and qRT-PCR. Similar to previous results, application of these eye irritants onto immortalized human corneal cells significantly induced EZR mRNA expression compared with in control cells. For cyclohexanol, ETOH, 2-methyl-1-pentanol and NaOH, EZR mRNA levels were increased by at approximately 1.2-, 1.5-, 3.2-and 1.8-fold when used to treat cells at a concentration inducing approximately 50% cell viability (cyclohexanol: 0.5%; ETOH: 15%; 2-methyl-1-pentanol: 2.5%; NaOH: 6.25 Â 10 À3 %). In contrast, the surfactants, TX-100 and CPB significantly increased the mRNA expression of EZR by 9.8-and 6.4-fold, respectively, at a cell survival rate of approximately 50% (TX-100: 1 Â 10 À2 %; CPB: 5 Â 10 À3 %).
This suggests that EZR expression is sensitive to surfactant stimuli. Despite such differences, all 6 eye irritants, regardless of their chemical categories, induced an increase in EZR mRNA expression in proportion to the decrease in cell viability ( Figure 4B ). Consistent with the increased mRNA levels, EZR protein expression and promoter activity also increased significantly (Figs. 4C and 4D ). Cell viability, EZR mRNA expression, and EZR promoter activity in immortalized human corneal cells in response to eye irritants are listed in Table 4 . Taken together, these results indicate that increased EZR expression in immortalized corneal cells reflects the degree of eye irritation induced by various types of eye irritants and that measurement of EZR expression is an excellent alternative in vitro test for evaluating eye irritation.
DISCUSSION
In this study, a proteomic approach was used to explore specific biomarkers for eye irritation that are expected to improve the performance of in vitro EITs. To date, in vitro EITs have evaluated tissue viability as the only criteria for eye irritation (Alepee et al., 2013; Kaluzhny et al., 2011; Pfannenbecker et al., 2013; Stern et al., 1998) . However, using this approach, errors can occur when distinguishing between weak-irritant and nonirritant materials or materials that interfere with cell viability measurement. This lowers the reliability of the results of alternative in vitro tests. To complement the ambiguous identification criteria of eye irritants by the alternative in vitro methods, numerous studies have attempted to develop specific biomarkers that are sensitive to eye irritants using 3D reconstructed models and cell-based assays Ko et al., 2018; Meloni et al., 2010) . In this study, alterations in the protein expression in SLSand BAC-treated MCTT HCE were analyzed by 2DE-gel/MALDI-TOF-MS analysis. Of the several 3D reconstructed human corneal models, MCTT HCE is derived from intact human corneal tissue and shows similarities to actual human corneal epithelium in terms of morphology, histological features, and biomarker expression (Jung et al., 2011) . Accordingly, we used MCTT HCE to investigate eye irritation biomarkers because this material reflects alterations in gene expression that are highly similar to irritated human corneal epithelial tissue. We identified proteins that were sensitively altered by eye irritants and whose functions are thought to be closely related to the intracellular responses of eye irritation. Overall proteomic analysis showed that the expression of 7 proteins was increased by at least 1.5-fold after application of SLS and BAC (TCTP, EIF4A, ACTR3, LDHB, enolase 1, CCT2, and EZR) compared with the negative control. The function of these proteins is known to be closely related to cell metabolism, apoptosis, proliferation, and motility, and these functions may cause cellular reactions that stimulate the eye. In addition to 3D reconstructed model-based test methods, cell-based in vitro tests have also been extensively studied in response to the replacement requirements for the Draize test (Cho et al., 2012; Kim et al., 2016; Kojima et al., 2013; Sakaguchi et al., 2011) . Most of these in vitro tests have several advantages, including objective measurement of inflammation potential, high-throughput, and low cost of experimentation . To establish a low-cost, high-efficiency in vitro alternative EIT employing an eye irritation biomarker, we examined the trends in expression of 7 identified genes in immortalized human corneal cells treated with SLS or BAC by qRT-PCR. Of these 7 genes, only EZR mRNA expression was significantly induced and an increase of up to 11-fold was observed. Although it is necessary to elucidate the intracellular pathways linking between SLS/BAC-induced eye irritation and EZR expression, we observed a concentration-dependent increase in EZR expression. Thus, we assumed that increased expression of EZR sensitively reflects the eye irritation potential.
On the other hand, in the case of EIF4A and LDHB, the expression of the protein was elevated to 9-and 17-fold in the eye irritants-treated RhCE, respectively, but no significant mRNA expression change was observed in the immortalized human corneal cells. LDHB is a subunit that constitutes the tetramer form enzymatically functional lactate dehydrogenase with lactate dehydrogenase A (Liang et al., 2016) . Recent studies have emphasized the correlation between LDHB expression and mitochondrial function. Kim et al. (2011) reported that inhibition of LDHB expression in liver cancer cells induces respiratory inhibition by mitochondrial dysfunction, thereby enhancing cell invasiveness. In addition, skeletal muscle of LDHB overexpression transgenic mice was shown to have enhanced mitochondrial enzyme activity, mitochondrial gene expression, and different concentrations of CPB, TX-100, cyclohexanol, ETOH, 2-mehtyl-1-pentanol, or NaOH. Cell viability assay was performed in triplicate. The data represent mean 6 SD (n ¼ 3). *p < .05. B, EZR mRNA expression was measured by RT-PCR and qRT-PCR following CPB, TX-100, cyclohexanol, ETOH, 2-mehtyl-1-pentanol, or NaOH treatment. qRT-PCR was performed in triplicate. The data represent mean 6 SD (n ¼ 3). *p < .05. C, EZR protein expression was measured by western blot following CPB, TX-100, cyclohexanol, ETOH, 2-mehtyl-1-pentanol, or NaOH treatment. D, EZR promoter activity was examined by luciferase assay following CPB, TX-100, cyclohexanol, ETOH, 2-mehtyl-1-pentanol, or NaOH treatment. The luciferase assay was performed in triplicate. The data represent mean 6 SD (n ¼ 3). *p < .05. Immortalized human corneal cells were treated with vehicle control or eye irritant chemicals. The cell viability, EZR mRNA level, and EZR promoter activity were examined by cell viability assay, qRT-PCR, and luciferase assay, respectively. Cell viability assay, qRT-PCR, and luciferase assay were performed in triplicate. The data represent mean 6
mitochondrial respiration capacity (Liang et al, 2016) . These studies suggest that LDHB expression might be increased upon the exposure to eye irritants to compensate disrupted mitochondrial function which is induced by eye irritation (Clouzeau et al., 2012; Xiang et al., 2016) to restore normal function of cells. EIF4A is a protein that exhibiting RNA-dependent ATPase and bidirectional RNA helicase activities (Gingras et al., 1999) . In recently, Fredriksson et al. (2014) demonstrated that hepatotoxic agent induced endoplasmic reticulum stress that sensitize toward TNFa-mediated hepatotoxicity in HepG2 cell is mediated by increased EIF4AI expression, which may explain the increased expression of EIF4A in response to eye irritants-induced cellular stress. Although the protein expression of EIF4A and LDHB was greatly increased when RhCE was treated with eye irritants, the fact that there was no significant change in mRNA expression in the cell line suggests that there are limits to the development of various in vitro EIT methods that utilize EIF4A and LDHB as biomarkers, such as reporter assay. This may be because only single time point, for example 16 6 1 h after chemical application, was examined to align the test method with EIT using MCTT HCE and accordingly, examination of other time points or time course can elucidate their possibility as a biomarker. We will confirm the possibility of EIF4A and LDHB as a biomarker of eye irritation by performing optimization of experiments using immortalized human corneal cells and application of various kinds of eye irritants in further study. Using confocal microscopy and immunohistochemistry, we showed that nuclear translocation of EZR occurs after SLS/BAC treatment. EZR is a cytoplasmic membrane protein that functions as a protein-tyrosine kinase substrate in microvilli. Although initially known to function only as a component of the cytoskeleton, many recent studies have shown that EZR is involved not only in cytoskeletal organization but also in many cellular signaling pathways (Louvet-Vallee, 2000) . These explanations led to studies of other cellular functions of EZR, including proliferation, apoptosis, cell motility and regulation of cell morphology (Gautreau et al., 2002; Louvet-Vallee, 2000) . Recent studies showed that EZR nuclear translocation is involved in the functional activities of EZR, such as cyclin A transcriptional suppression and subsequent inhibition of cell proliferation (Kishore et al., 2005) as well as modification of cytoskeletal structures (Kaul et al., 1999) . In addition, Ko et al. (2018) found increased translocation into the cytoplasm and nucleus of EZR with destruction of cell membrane in the RhCE model EpiOcular treated with 14 eye irritants. We inferred that EZR expression/translocation induced by eye irritants is an intracellular response against external stimuli that cause cell damage and growth inhibition, which requires further examination.
In addition to SLS/BAC treatment, CPB, TX-100, cyclohexanol, ETOH, 2-methyl-1-pentanol, and NaOH application to immortalized human corneal cells increased the expression of EZR, with EZR mRNA levels increased by up to 10-fold. The increased EZR expression was concentration-dependent for treated irritants regardless of the chemical category of the irritants. These results indicate that ocular irritants induce EZR expression in proportion to the degree of irritation, regardless of the chemical class, suggesting that increased EZR expression may be a general biomarker of eye irritation. To increase the reliability of EZR expression as a general eye-irritation biomarker, subsequent studies should test chemicals from a wider variety of chemical groups.
In fact, even if EZR has potential as a sensitive biomarker to effectively discriminate eye irritation, high-throughput screening is difficult if the expression is measured by a complex assay that requires several steps such as qRT-PCR or western blotting. To overcome these limitations in the field of alternative in vitro skin sensitization tests, the interleukin-8 luciferase assay was developed using interleukin-8 as a biomarker to identify skin sensitizers (Kimura et al., 2015; Takahashi et al., 2011) . Additionally, Emter et al. (2010) noted that Kelch-like ECH-related protein 1-nuclear factor 2-related factor 2-antioxidant response element (Keap1-Nrf2-ARE) in a regulatory pathway is activated by most skin sensitizers. Accordingly, Emter et al. (2010) produced a human HaCaT keratinocyte cell line containing a reporter construct containing the ARE of human AKR1C2 gene and developed a luciferase assay capable of discriminating a skin sensitizer known as a "keratinosens assay". This assay provides an accurate, convenient, and high-throughput alternative test method for discriminating skin sensitizers. Thus, we also examined the effect of eye irritants on EZR promoter activity using a luciferase assay. As a result, we found that EZR promoter activity was increased in a concentration-dependent manner by all 8 eye irritants evaluated in this experiment, suggesting that measurement of EZR promoter activity also sensitively reflects the intensity of eye irritation. However, because the increase in EZR promoter activity tends to be smaller than the increase in EZR mRNA expression when tested under the same conditions (Table 4) , additional studies are necessary to improve the experimental conditions of the EZR reporter assay.
In conclusion, we identified EZR as a candidate biomarker of eye irritation using MCTT HCE through a proteomics approach and confirmed its utility in immortalized human corneal cells. Although future studies are needed to establish criteria for the threshold of specific alteration degrees in EZR expression that can distinguish between eye irritants and nonirritants using more reference chemicals, we identified EZR as a potential candidate biomarker for identifying eye irritation.
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